{
  "id": "3d3ad834acde472e",
  "title": "EQT Life Sciences-Backed AgomAb Falls After $200 Million IPO",
  "description": "AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, closed 8.4% below its IPO price in its trading debut Friday after the firm raised $200 million in a listing.",
  "content": "AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, closed 8.4% below its IPO price in its trading debut Friday after the firm raised $200 million in a listing.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2026-02-06/eqt-life-sciences-backed-agomab-falls-8-after-200-million-ipo",
  "published_at": "2026-02-06T17:43:45+00:00",
  "fetched_at": "2026-02-07T00:27:41.919994+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "ipo",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "EQT Life Sciences-Backed AgomAb Falls After $200 Million IPO",
    "description": "AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, closed 8.4% below its IPO price in its trading debut Friday after the firm raised $200 million in a listing.",
    "url": "https://www.bloomberg.com/news/articles/2026-02-06/eqt-life-sciences-backed-agomab-falls-8-after-200-million-ipo",
    "published": "2026-02-06T17:43:45+00:00",
    "source": "Bloomberg Markets"
  }
}